7Baggers

We provide you with 20 years of free, institutional-grade data for IRWD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRWD. Explore the full financial landscape of IRWD stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$11,072
NameActionSharesAvg PriceAmountReported Date
DENNER ALEXANDER JGrant, award...etc11,7182025-09-17
Gaskins Tammi LSale-1,316$0.84$1,1052025-08-13
Martini Gregory S.Sale-1,265$0.84$1,0632025-08-13
John MinardoSale-7,754$0.84$6,5132025-08-13
Silver RonaldSale-2,846$0.84$2,3912025-08-13
DENNER ALEXANDER JGrant, award...etc24,1932025-06-17
Currie Mark GGrant, award...etc45,0002025-06-12
McHugh JulieGrant, award...etc45,0002025-06-12
Dreyfus AndrewGrant, award...etc45,0002025-06-12
DENNER ALEXANDER JGrant, award...etc45,0002025-06-12
Shepard JayGrant, award...etc45,0002025-06-12
Kessler Marla LGrant, award...etc45,0002025-06-12
Duane Jon RGrant, award...etc45,0002025-06-12
Moukheibir CatherineGrant, award...etc45,0002025-06-12
Gaskins Tammi LSale-2,563$0.58$1,4872025-05-20
MCCOURT Thomas AGrant, award...etc540,0002025-05-20
MCCOURT Thomas ASale-13,353$0.58$7,7452025-05-20
DENNER ALEXANDER JGrant, award...etc10,4162025-04-04
Gaskins Tammi LInitial2025-03-21
Martini Gregory S.Sale-12,052$1.76$21,2122025-02-12
John MinardoSale-38,938$1.76$68,5312025-02-12
John MinardoGrant, award...etc122,2222025-02-12
Silver RonaldSale-12,048$1.76$21,2042025-02-12
MCCOURT Thomas ASale-139,064$1.76$244,7532025-02-12
Shetzline MichaelSale-41,269$1.76$72,6332025-02-12
Shetzline MichaelGrant, award...etc133,3332025-02-12
Martini Gregory S.Initial2025-01-29
Martini Gregory S.Grant, award...etc111,1112025-01-29
Silver RonaldGrant, award...etc133,3332025-01-29
MCCOURT Thomas AGrant, award...etc147,3542025-01-22
Shetzline MichaelGrant, award...etc48,2242025-01-22
John MinardoGrant, award...etc40,1872025-01-22
DENNER ALEXANDER JGrant, award...etc4,2492024-12-18
Emany Sravan KumarSale-11,001$4.08$44,8842024-11-20
Davis AndrewSale-5,360$4.08$21,8692024-11-20
DENNER ALEXANDER JGrant, award...etc3,2822024-09-18
John MinardoSale-9,910$4.27$42,3162024-08-14
Silver RonaldSale-3,107$4.27$13,2672024-08-14
Moukheibir CatherineGrant, award...etc24,3112024-06-21
Kessler Marla LGrant, award...etc24,3112024-06-21
Currie Mark GGrant, award...etc24,3112024-06-21
DENNER ALEXANDER JGrant, award...etc24,3112024-06-21
Dreyfus AndrewGrant, award...etc24,3112024-06-21
Duane Jon RGrant, award...etc24,3112024-06-21
McHugh JulieGrant, award...etc24,3112024-06-21
Shepard JayGrant, award...etc24,3112024-06-21
DENNER ALEXANDER JGrant, award...etc2,5722024-06-18
McHugh JulieSale-22,766$6.29$143,1982024-06-12
Moukheibir CatherineSale-80,000$6.36$508,8002024-06-10
John MinardoSale-17,404$6.45$112,2562024-05-22
Shetzline MichaelSale-16,128$6.45$104,0262024-05-22
Davis AndrewSale-22,725$6.45$146,5762024-05-22
MCCOURT Thomas ASale-67,618$6.45$436,1362024-05-22
Emany Sravan KumarSale-18,280$6.64$121,3792024-05-20
DENNER ALEXANDER JGrant, award...etc1,6622024-03-19
MCCOURT Thomas ADerivatives Exercise120,2982024-03-12
Shetzline MichaelDerivatives Exercise34,9362024-03-12
John MinardoDerivatives Exercise32,7522024-03-12
Emany Sravan KumarDerivatives Exercise37,1202024-03-12
Davis AndrewDerivatives Exercise37,1202024-03-12
Duane Jon ROpen Market Purchase6,920$8.72024-03-08
MCCOURT Thomas AGrant, award...etc264,8762024-03-07
Emany Sravan KumarOpen Market Purchase10,684$9.382024-03-06
Silver RonaldGrant, award...etc27,2132024-02-14
Silver RonaldSale-7,908$15.24$120,5182024-02-14
Davis AndrewGrant, award...etc65,3122024-02-14
Davis AndrewSale-9,846$15.24$150,0532024-02-14
Emany Sravan KumarGrant, award...etc65,3122024-02-14
MCCOURT Thomas ASale-177,164$15.24$2,699,9792024-02-14
John MinardoGrant, award...etc54,4272024-02-14
John MinardoSale-47,380$15.24$722,0712024-02-14
Shetzline MichaelGrant, award...etc54,4272024-02-14
Shetzline MichaelSale-38,618$15.24$588,5382024-02-14
Emany Sravan KumarSale-41,332$14.9$615,8472024-02-12
Emany Sravan KumarGrant, award...etc85,0002024-01-19
John MinardoGrant, award...etc79,9812024-01-19
Shetzline MichaelGrant, award...etc57,9712024-01-19
MCCOURT Thomas AGrant, award...etc249,6172024-01-19
Moukheibir CatherineGrant, award...etc1,5722023-12-19
DENNER ALEXANDER JGrant, award...etc1,3472023-12-19
Kessler Marla LSale-9,926$11.19$111,0722023-12-18
Davis AndrewSale-3,287$9.69$31,8512023-11-22
Emany Sravan KumarSale-6,661$9.44$62,8802023-11-20
Moukheibir CatherineGrant, award...etc2,0982023-09-19
DENNER ALEXANDER JGrant, award...etc1,7982023-09-19
Emany Sravan KumarOpen Market Purchase36,072$8.322023-09-18
Silver RonaldGrant, award...etc8,0002023-08-31
John MinardoSale-7,045$10.04$70,7322023-08-16
Silver RonaldSale-1,976$10.04$19,8392023-08-16
Moukheibir CatherineGrant, award...etc22,3502023-06-22
McHugh JulieGrant, award...etc22,3502023-06-22
Shepard JayGrant, award...etc22,3502023-06-22
Kessler Marla LGrant, award...etc22,3502023-06-22
Duane Jon RGrant, award...etc22,3502023-06-22
Currie Mark GGrant, award...etc22,3502023-06-22
DENNER ALEXANDER JGrant, award...etc22,3502023-06-22
Dreyfus AndrewGrant, award...etc22,3502023-06-22
Moukheibir CatherineGrant, award...etc1,5862023-06-20
DENNER ALEXANDER JGrant, award...etc1,3592023-06-20
MCCOURT Thomas ASale-26,632$10.7$284,9622023-06-01
Login to see more insider transactions
The information provided in this report about IRWD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Ironwood Pharmaceuticals, Inc
(NASDAQ:IRWD) 

IRWD stock logo

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chroni...

Founded: 1998
Full Time Employees: 317
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends